T2 Biosystems Balance Sheet Health
Financial Health criteria checks 0/6
T2 Biosystems has a total shareholder equity of $-11.7M and total debt of $11.9M, which brings its debt-to-equity ratio to -101.8%. Its total assets and total liabilities are $18.1M and $29.8M respectively.
Key information
-101.8%
Debt to equity ratio
US$11.92m
Debt
| Interest coverage ratio | n/a |
| Cash | US$2.08m |
| Equity | -US$11.71m |
| Total liabilities | US$29.79m |
| Total assets | US$18.08m |
Recent financial health updates
Recent updates
Insufficient Growth At T2 Biosystems, Inc. (NASDAQ:TTOO) Hampers Share Price
Apr 18
T2 Biosystems to develop, commercialize diagnostic test for early Lyme disease
Oct 13T2 Biosystems announces BARDA exercise of contract option 3 valued at $3.7M
Sep 29T2 Biosystems stock rises ~17% after hours on Baltic region distribution agreement
Sep 22T2 Biosystems' Survival Riddle
Aug 26T2 Biosystems Q2 2022 Earnings Preview
Aug 12T2 Biosystems drops 4% on Q2 guidance and 2022 outlook
Jul 06Financial Position Analysis
Short Term Liabilities: TTOO has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: TTOO has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: TTOO has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: TTOO's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TTOO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: TTOO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 1.3% each year